The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Apatinib plus etoposide as second-or higher-line treatment in recurrent or metastatic triple-negative breast cancer: A single-arm, open label, prospective, phase II clinical trial.
 
Mengru Cao
No Relationships to Disclose
 
Hailing Lu
No Relationships to Disclose
 
Shi Yan
No Relationships to Disclose
 
Hui Pang
No Relationships to Disclose
 
Lichun Sun
No Relationships to Disclose
 
Chunhong Li
No Relationships to Disclose
 
Xuesong Chen
No Relationships to Disclose
 
Wei Liu
No Relationships to Disclose
 
Jing Hu
No Relationships to Disclose
 
Jian Huang
No Relationships to Disclose
 
Ying Xing
No Relationships to Disclose
 
Yingqi Chen
No Relationships to Disclose
 
Ting He
No Relationships to Disclose
 
Danni Zhao
No Relationships to Disclose
 
Yuanyuan Sun
No Relationships to Disclose
 
Lin Zhao
No Relationships to Disclose
 
Xiaomeng Liu
No Relationships to Disclose
 
Ningzhi Zhang
No Relationships to Disclose
 
Li Cai
No Relationships to Disclose